< Go to adacap.com| This site is for health care professionals only

Novartis Satellite Symposia at the Virtual ESMO Congress 2021

Cutting through the noise: How Do GEP-NET Patients Stand to Benefit From PRRT?

Cutting through the noise: How Do GEP-NET Patients Stand to Benefit From PRRT?

September 20, 2021 I 8:45 - 10:15 CEST I Channel 6

Actionable Targets in Advanced Prostate Cancer: The Potential of Molecular Profiling and Radioligand Therapy

Actionable Targets in Advanced Prostate Cancer: The Potential of Molecular Profiling and Radioligand Therapy

September 20, 2021 I 10:30 - 12:00 CEST I Channel 6

Explore Pipeline Explore Clinical Trials